Virax Biolabs Group (VRAX) Q3 2024 Earnings
VRAX·Reported November 19, 2024·Before market open
Virax Biolabs Group reported Q3 2024 revenue of $5.0K, missed analyst consensus of $3.0M by $3.0M. Diluted EPS came in at $-0.89.
Revenue
$5.0Kmissed by $3.0M
Consensus: $3.0MDiluted EPS
$-0.89
SEC Filings
Earnings release8-K not filed yet
Quarterly report10-Q / 10-K not filed yet
Filings will appear here once submitted to SEC EDGAR.
Q3 2024 Earnings FAQ
Common questions about Virax Biolabs Group's Q3 2024 earnings report.
Virax Biolabs Group (VRAX) reported Q3 2024 earnings on November 19, 2024 before market open.
Virax Biolabs Group reported revenue of $5.0K and diluted EPS of $-0.89 for Q3 2024.
Revenue missed the consensus estimate of $3.0M by $3.0M.